Revenue of $347 million exceeds high end of guidance as momentum continues into Q3
Q2 2021 Summary
- Record GAAP revenue for a second quarter of $347 million, up 15 percent year over year
- Record orders for a second quarter up 33 percent year over year
- Strong GAAP operating income of $25 million, up 50 percent year over year
- Record non-GAAP operating income for a second quarter of $60 million, up 38 percent year over year
- Strong diluted GAAP EPS of $0.13 and record diluted non-GAAP EPS for a second quarter of $0.35
- Cash and short-term investments of $265 million as of June 30, 2021
AUSTIN, Texas — (BUSINESS WIRE) — July 29, 2021 — National Instruments Corporation (Nasdaq: NATI) today announced Q2 2021 revenue of $347 million, up 15 percent year over year, a record for a second quarter.
In Q2 2021 the value of the company's orders was up 33 percent year over year. For Q2 2021, year over year orders were up 22 percent in the Americas, up 51 percent in EMEA, and up 36 percent in APAC.
Geographic revenue in U.S. dollar terms for Q2 2021 compared with Q2 2020 was up 11 percent in the Americas, up 17 percent in APAC and up 19 percent in EMEA. Historical revenue from these three regions can be found on NI’s investor website at www.ni.com/nati.
In Q2, GAAP gross margin was 71 percent and non-GAAP gross margin was 75 percent. Total GAAP operating expenses were $223 million. Total non-GAAP operating expenses were $200 million. GAAP operating income for Q2 was $25 million with non-GAAP operating income of $60 million. GAAP net income for Q2 was $17 million and non-GAAP net income was $47 million, with GAAP diluted EPS of $0.13 and non-GAAP diluted EPS of $0.35. Our GAAP diluted EPS was above the high-end of our guidance while our non-GAAP diluted EPS was at the high-end of our guidance.
“We were very pleased with the strong results in the second quarter with revenue exceeding the high end of guidance. Momentum in customer demand continued with the total value of orders for Q2 up 33 percent year-over-year. This represents record orders for a second quarter and double-digit growth year-over-year across all industries and all regions,” said Eric Starkloff, NI President and CEO. “We believe these results are proof that our strategy is working, and our continued market focus is paying off.”
"We delivered record non-GAAP Operating Income for a second quarter, up 38 percent year-over-year. While we continue to invest in areas of critical importance, our focus on driving scale is making our business model more resilient,” said Karen Rapp, NI CFO. “We remain committed to the execution of our growth strategy while also improving our profitability in order to ensure our priority of maximizing shareholder value."
As of June 30, 2021, NI had $265 million in cash and short-term investments. During the second quarter, NI paid $36 million in dividends. The NI Board of Directors approved a quarterly dividend of $0.27 per share payable on August 30, 2021, to stockholders of record on August 9, 2021.
NI's non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the NI's GAAP and non-GAAP results are included as part of this news release.
H1 2021 Summary
- Record GAAP revenue for a first half of $682 million, up 12 percent year over year
- Strong GAAP operating income of $34 million
- Record non-GAAP operating income for a first half of $111 million
- Strong diluted GAAP EPS of $0.16 and record diluted non-GAAP EPS for a first half of $0.67
Guidance
- Q3 GAAP revenue to be in the range of $355 million to $385 million, up 20 percent year over year at the midpoint
- GAAP diluted EPS to be in the range of $0.10 to $0.24 for Q3, up 21 cents year over year at the midpoint
- Non-GAAP diluted EPS expected to be in the range of $0.31 to $0.45, up 65 percent year over year at the midpoint
Conference Call Information
Interested parties can listen to the Q2 2021 earnings conference call with NI Management today, at ni.com/call or by dial (855) 212-2361 and enter confirmation code 6289401. Replay information is available by calling (855) 859-2056, confirmation code 6289401, shortly after the call through August 2 at 11:59 p.m. CT or by visiting the company’s website at www.ni.com/call.
Non-GAAP Presentation
To supplement NI’s financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including GAAP revenue or net sales, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin, diluted EPS and EBITDA. A reconciliation of the adjustments to GAAP results is included in the tables below. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including without limitation those statements about our expectations of accelerating growth and progress to meet long-term financial model, our continued momentum across regions and business units, our opportunities to drive growth, profitability and efficiency in our business, confidence in our software strategy, and our guidance and expectations for our Q3 2021 revenue, diluted EPS, backlog and lead times. These statements are subject to a number of risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively manage our partners and distribution channels; interruptions in our technology systems; cyber-attacks; the dependency of our product revenue on certain industries and the risk of contractions in such industries; fluctuations in demand for our products including orders from our large customers; concentration of credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; component shortages; longer delivery lead times from our suppliers; risk of product liability claims; dependence on our proprietary rights and risks of intellectual property litigation; the continued service of key management and technical personnel; the ability to comply with environmental laws and associated costs; our ability to maintain our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our ability to achieve the benefits of employee restructuring plans; our exposure to large orders; our ability to effectively manage our operating expenses and meet budget; expense overruns; manufacturing inefficiencies and the level of capacity utilization; fluctuations in our quarterly results due to factors outside of our control; our outstanding debt; seasonal variation in our revenues; our ability to comply with laws and regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships; risks related to currency fluctuations; adverse effects of price changes; and changes in accounting principles. The company directs readers to its Form 10-K for the year ended December 31, 2020, and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.
About NI
LabVIEW, NI (ni.com) develops high-performance automated test and automated measurement systems to help you solve your engineering challenges now and into the future. Our open, software-defined platform uses modular hardware and an expansive ecosystem to help you turn powerful possibilities into real solutions. (NATI-F)
National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
National Instruments |
||||||
Condensed Consolidated Balance Sheets |
||||||
(in thousands) |
||||||
|
June 30, |
December 31, |
||||
|
2021 |
2020 |
||||
|
(unaudited) |
|
||||
Assets |
|
|
||||
Cash and cash equivalents |
$ |
250,421 |
|
$ |
260,232 |
|
Short-term investments |
14,110 |
|
59,923 |
|
||
Accounts receivable, net |
258,641 |
|
266,869 |
|
||
Inventories, net |
211,023 |
|
194,012 |
|
||
Prepaid expenses and other current assets |
80,121 |
|
68,470 |
|
||
Total current assets |
814,316 |
|
849,506 |
|
||
Property and equipment, net |
250,761 |
|
254,399 |
|
||
Goodwill |
483,136 |
|
467,547 |
|
||
Intangible assets, net |
149,126 |
|
172,719 |
|
||
Operating lease right-of-use assets |
57,812 |
|
67,674 |
|
||
Other long-term assets |
76,878 |
|
72,643 |
|
||
Total assets |
$ |
1,832,029 |
|
$ |
1,884,488 |
|
|
|
|
||||
Liabilities and Stockholders' Equity |
|
|
||||
Accounts payable and accrued expenses |
$ |
56,477 |
|
$ |
51,124 |
|
Accrued compensation |
68,932 |
|
87,068 |
|
||
Deferred revenue - current |
125,986 |
|
132,151 |
|
||
Operating lease liabilities - current |
13,389 |
|
15,801 |
|
||
Other taxes payable |
39,339 |
|
48,129 |
|
||
Debt, current |
— |
|
5,000 |
|
||
Other current liabilities |
26,854 |
|
42,578 |
|
||
Total current liabilities |
330,977 |
|
381,851 |
|
||
Deferred income taxes |
28,359 |
|
25,288 |
|
||
Income tax payable - non-current |
54,195 |
|
61,623 |
|
||
Deferred revenue - non-current |
34,624 |
|
36,335 |
|
||
Operating lease liabilities - non-current |
29,512 |
|
35,854 |
|
||
Debt, noncurrent |
100,000 |
|
92,036 |
|
||
Other long-term liabilities |
18,710 |
|
26,630 |
|
||
Total liabilities |
$ |
596,377 |
|
$ |
659,617 |
|
Stockholders' equity: |
|
|
||||
Common stock |
1,330 |
|
1,312 |
|
||
Additional paid-in capital |
1,087,622 |
|
1,033,284 |
|
||
Retained earnings |
161,475 |
|
211,101 |
|
||
Accumulated other comprehensive loss |
(14,775 |
) |
(20,826 |
) |
||
Total stockholders' equity |
1,235,652 |
|
1,224,871 |
|
||
Total liabilities and stockholders' equity |
$ |
1,832,029 |
|
$ |
1,884,488 |
|
National Instruments |
||||||||||||||||
Condensed Consolidated Statements of Income |
||||||||||||||||
(in thousands, except per share data, unaudited) |
||||||||||||||||
|
|
|
|
|||||||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||||||
|
June 30, |
June 30, |
||||||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||||||
|
|
|
|
|
||||||||||||
Net sales: |
|
|
|
|
||||||||||||
Product |
$ |
306,490 |
|
$ |
266,261 |
|
$ |
601,583 |
|
$ |
540,239 |
|
||||
Software maintenance |
40,206 |
|
35,068 |
|
80,295 |
|
70,470 |
|
||||||||
Total net sales |
346,696 |
|
301,329 |
|
681,878 |
|
610,709 |
|
||||||||
|
|
|
|
|
||||||||||||
Cost of sales: |
|
|
|
|
||||||||||||
Product |
95,722 |
|
83,795 |
|
187,379 |
|
165,866 |
|
||||||||
Software maintenance |
3,516 |
|
2,106 |
|
7,273 |
|
3,796 |
|
||||||||
Total cost of sales |
99,238 |
|
85,901 |
|
194,652 |
|
169,662 |
|
||||||||
|
|
|
|
|
||||||||||||
Gross profit |
247,458 |
|
215,428 |
|
487,226 |
|
441,047 |
|
||||||||
|
71.4% |
|
|
71.5% |
|
|
71.5% |
|
|
72.2% |
|
|
||||
Operating expenses: |
|
|
|
|
||||||||||||
Sales and marketing |
111,199 |
|
105,419 |
|
227,983 |
|
221,165 |
|
||||||||
Research and development |
81,434 |
|
64,225 |
|
161,520 |
|
135,846 |
|
||||||||
General and administrative |
30,277 |
|
29,369 |
|
63,636 |
|
55,549 |
|
||||||||
Total operating expenses |
222,910 |
|
199,013 |
|
453,139 |
|
412,560 |
|
||||||||
Gain on sale of business/assets |
— |
|
— |
|
— |
|
159,753 |
|
||||||||
Operating income |
24,548 |
|
16,415 |
|
34,087 |
|
188,240 |
|
||||||||
Other expense |
(2,963 |
) |
(1,143 |
) |
(8,031 |
) |
(583 |
) |
||||||||
Income before income taxes |
21,585 |
|
15,272 |
|
26,056 |
|
187,657 |
|
||||||||
Provision for income taxes |
4,279 |
|
4,383 |
|
4,254 |
|
44,113 |
|
||||||||
Net income |
$ |
17,306 |
|
$ |
10,889 |
|
$ |
21,802 |
|
$ |
143,544 |
|
||||
|
|
|
|
|
||||||||||||
Basic earnings per share |
$ |
0.13 |
|
$ |
0.08 |
|
$ |
0.17 |
|
$ |
1.10 |
|
||||
Diluted earnings per share |
$ |
0.13 |
|
$ |
0.08 |
|
$ |
0.16 |
|
$ |
1.09 |
|
||||
|
|
|
|
|
||||||||||||
Weighted average shares outstanding - |
|
|
|
|
||||||||||||
Basic |
132,498 |
|
131,014 |
|
131,996 |
|
130,813 |
|
||||||||
Diluted |
133,539 |
|
131,602 |
|
133,157 |
|
131,499 |
|
||||||||
|
|
|
|
|
||||||||||||
Dividends declared per share |
$ |
0.27 |
|
$ |
0.26 |
|
$ |
0.54 |
|
$ |
0.52 |
|
||||
Condensed Consolidated Statements of Cash Flows |
||||||
(in thousands, unaudited) |
||||||
|
Six Months Ended June 30, |
|||||
|
2021 |
2020 |
||||
|
|
|||||
Cash flow from operating activities: |
|
|
||||
Net income |
$ |
21,802 |
|
$ |
143,544 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
||||
Disposal gains on sale of business/asset |
— |
|
(159,753 |
) |
||
Depreciation and amortization |
50,024 |
|
38,341 |
|
||
Stock-based compensation |
37,208 |
|
27,335 |
|
||
Loss from equity-method investees |
5,360 |
|
1,932 |
|
||
Deferred income taxes |
1,301 |
|
2,711 |
|
||
Net change in operating assets and liabilities |
(63,372 |
) |
47,388 |
|
||
Net cash provided by operating activities |
52,323 |
|
101,498 |
|
||
|
|
|
||||
Cash flow from investing activities: |
|
|
||||
Acquisitions, net of cash received |
(19,784 |
) |
— |
|
||
Capital expenditures |
(17,411 |
) |
(25,362 |
) |
||
Proceeds from sale of assets/business, net of cash divested |
— |
|
160,266 |
|
||
Capitalization of internally developed software |
(721 |
) |
(3,108 |
) |
||
Additions to other intangibles |
(1,519 |
) |
(630 |
) |
||
Payments to acquire equity-method investments |
(12,551 |
) |
— |
|
||
Purchases of short-term investments |
— |
|
(206,330 |
) |
||
Sales and maturities of short-term investments |
45,671 |
|
306,955 |
|
||
Net cash (used in) provided by investing activities |
(6,315 |
) |
231,791 |
|
||
|
|
|
||||
Cash flow from financing activities: |
|
|
||||
Proceeds from revolving loan facility |
100,000 |
|
20,000 |
|
||
Proceeds from term loan |
— |
|
70,000 |
|
||
Payments on term loan |
(98,750 |
) |
— |
|
||
Debt issuance costs |
(1,993 |
) |
(1,480 |
) |
||
Proceeds from issuance of common stock |
17,239 |
|
17,252 |
|
||
Repurchase of common stock |
— |
|
(23,680 |
) |
||
Dividends paid |
(71,428 |
) |
(68,156 |
) |
||
Net cash (used in) provided by financing activities |
(54,932 |
) |
13,936 |
|
||
|
|
|
||||
Impact of changes in exchange rates on cash |
(887 |
) |
(636 |
) |
||
|
|
|
||||
Net change in cash and cash equivalents |
(9,811 |
) |
346,589 |
|
||
Cash and cash equivalents at beginning of period |
260,232 |
|
194,616 |
|
||
Cash and cash equivalents at end of period |
$ |
250,421 |
|
$ |
541,205 |
|
The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges, gains on sale of business/assets, and other that were recorded in the line items indicated below (unaudited) (in thousands) |
||||||||||||
|
|
|
|
|
||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||
|
June 30, |
June 30, |
||||||||||
|
|
|
|
|
||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||
Stock-based compensation |
|
|
|
|
||||||||
Cost of sales |
$ |
1,191 |
|
$ |
932 |
|
$ |
2,305 |
|
$ |
1,736 |
|
Sales and marketing |
6,922 |
|
6,467 |
|
12,617 |
|
11,642 |
|
||||
Research and development |
6,180 |
|
4,428 |
|
11,893 |
|
7,947 |
|
||||
General and administrative |
5,854 |
|
3,404 |
|
10,520 |
|
6,008 |
|
||||
Provision for income taxes |
(3,916 |
) |
(2,905 |
) |
(7,241 |
) |
(4,406 |
) |
||||
Total |
$ |
16,231 |
|
$ |
12,326 |
|
$ |
30,094 |
|
$ |
22,927 |
|
|
|
|
|
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments |
|
|
|
|
||||||||
Net sales |
$ |
738 |
|
$ |
— |
|
$ |
1,551 |
|
$ |
— |
|
Cost of sales |
4,226 |
|
635 |
|
8,497 |
|
1,381 |
|
||||
Sales and marketing |
2,357 |
|
480 |
|
4,528 |
|
966 |
|
||||
Research and development |
— |
|
28 |
|
— |
|
55 |
|
||||
Other expense |
554 |
|
117 |
|
948 |
|
241 |
|
||||
Provision for income taxes |
(979 |
) |
(133 |
) |
(1,969 |
) |
(290 |
) |
||||
Total |
$ |
6,896 |
|
$ |
1,127 |
|
$ |
13,555 |
|
$ |
2,353 |
|
|
|
|
|
|
||||||||
Acquisition transaction and integration costs, restructuring charges, and other(1)(2) |
|
|
|
|
||||||||
Cost of sales |
$ |
(118 |
) |
$ |
— |
|
$ |
(43 |
) |
$ |
20 |
|
Sales and marketing |
839 |
|
1,239 |
|
5,487 |
|
7,612 |
|
||||
Research and development |
548 |
|
147 |
|
1,036 |
|
4,816 |
|
||||
General and administrative |
873 |
|
3,399 |
|
6,539 |
|
2,385 |
|
||||
Gain on sale of business/assets |
— |
|
— |
|
— |
|
(159,753 |
) |
||||
Other expense |
280 |
|
— |
|
4,006 |
|
128 |
|
||||
Provision for income taxes |
(578 |
) |
(78 |
) |
(3,463 |
) |
34,676 |
|
||||
Total |
$ |
1,844 |
|
$ |
4,707 |
|
$ |
13,562 |
|
$ |
(110,116 |
) |
(1): During the first quarter of 2020, we recognized a gain of approximately $160 million related to the divestiture of AWR, presented within "Gain on sale of business/assets". |
||||||||||||
(2): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments. |
||||||||||||
|
|
|
|
|
||||||||
Capitalization and amortization of internally developed software costs |
|
|
|
|
||||||||
Cost of sales |
$ |
6,227 |
|
$ |
7,144 |
|
$ |
13,101 |
|
$ |
14,226 |
|
Research and development |
(495 |
) |
(1,181 |
) |
(721 |
) |
(3,095 |
) |
||||
Provision for income taxes |
(1,204 |
) |
(1,252 |
) |
(2,600 |
) |
(2,337 |
) |
||||
Total |
$ |
4,528 |
|
$ |
4,711 |
|
$ |
9,780 |
|
$ |
8,794 |
|
National Instruments |
||||||||||||
Reconciliation of GAAP to Non-GAAP Measures |
||||||||||||
(in thousands, unaudited) |
||||||||||||
|
|
|
|
|
||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||
|
June 30, |
June 30, |
||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||
|
|
|
|
|
||||||||
Reconciliation of Net sales to Non-GAAP Net sales |
|
|
|
|
||||||||
Net sales, as reported |
$ |
346,696 |
|
$ |
301,329 |
|
$ |
681,878 |
|
$ |
610,709 |
|
plus: Impact of acquisition-related fair value adjustments |
|
738 |
|
|
— |
|
|
1,551 |
|
|
— |
|
Non-GAAP net sales |
$ |
347,434 |
|
|
301,329 |
|
|
683,429 |
|
$ |
610,709 |
|
|
|
|
|
|
||||||||
Reconciliation of Gross Profit to Non-GAAP Gross Profit |
|
|
|
|
||||||||
Gross profit, as reported |
$ |
247,458 |
|
$ |
215,428 |
|
$ |
487,226 |
|
$ |
441,047 |
|
Stock-based compensation |
|
1,191 |
|
|
932 |
|
|
2,305 |
|
|
1,736 |
|
Amortization of acquisition-related intangibles and fair value adjustments |
|
4,964 |
|
|
635 |
|
|
10,048 |
|
|
1,381 |
|
Acquisition transaction and integration costs, restructuring charges and other |
|
(118 |
) |
|
— |
|
|
(43 |
) |
|
20 |
|
Amortization of internally developed software costs |
|
6,227 |
|
|
7,144 |
|
|
13,101 |
|
|
14,226 |
|
Non-GAAP gross profit |
$ |
259,722 |
|
$ |
224,139 |
|
$ |
512,637 |
|
$ |
458,410 |
|
Non-GAAP gross margin |
74.8% |
74.4% |
75.0% |
75.1% |
||||||||
|
|
|
|
|
||||||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses |
|
|
|
|
||||||||
Operating expenses, as reported |
$ |
222,910 |
|
$ |
199,013 |
|
$ |
453,139 |
|
$ |
412,560 |
|
Stock-based compensation |
|
(18,956 |
) |
|
(14,299 |
) |
|
(35,030 |
) |
|
(25,597 |
) |
Amortization of acquisition-related intangibles and fair value adjustments |
|
(2,357 |
) |
|
(508 |
) |
|
(4,528 |
) |
|
(1,021 |
) |
Acquisition transaction and integration costs, restructuring charges and other |
|
(2,260 |
) |
|
(4,785 |
) |
|
(13,062 |
) |
|
(14,813 |
) |
Capitalization of internally developed software costs |
|
495 |
|
|
1,181 |
|
|
721 |
|
|
3,095 |
|
Non-GAAP operating expenses |
$ |
199,832 |
|
$ |
180,602 |
|
$ |
401,240 |
|
$ |
374,224 |
|
|
|
|
|
|
||||||||
Reconciliation of Operating Income to Non-GAAP Operating Income |
|
|
|
|
||||||||
Operating income, as reported |
$ |
24,548 |
|
$ |
16,415 |
|
$ |
34,087 |
|
$ |
188,240 |
|
Stock-based compensation |
|
20,147 |
|
|
15,231 |
|
|
37,335 |
|
|
27,333 |
|
Amortization of acquisition-related intangibles and fair value adjustments |
|
7,321 |
|
|
1,143 |
|
|
14,576 |
|
|
2,402 |
|
Acquisition transaction and integration costs, restructuring charges and other |
|
2,142 |
|
|
4,785 |
|
|
13,019 |
|
|
14,833 |
|
Net amortization of internally developed software costs |
|
5,732 |
|
|
5,963 |
|
|
12,380 |
|
|
11,131 |
|
Gain on sale of business/assets |
|
— |
|
|
— |
|
|
— |
|
|
(159,753 |
) |
Non-GAAP operating income |
$ |
59,890 |
|
$ |
43,537 |
|
$ |
111,397 |
|
$ |
84,186 |
|
Non-GAAP operating margin |
17.2% |
14.4% |
16.3% |
13.8% |
||||||||
|
|
|
|
|
||||||||
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(1) |
|
|
|
|
||||||||
Provision for income taxes, as reported |
$ |
4,279 |
|
$ |
4,383 |
|
$ |
4,254 |
|
$ |
44,113 |
|
Stock-based compensation |
|
3,916 |
|
|
2,905 |
|
|
7,241 |
|
|
4,406 |
|
Amortization of acquisition-related intangibles and fair value adjustments |
|
979 |
|
|
133 |
|
|
1,969 |
|
|
290 |
|
Acquisition transaction and integration costs, restructuring charges and other |
|
578 |
|
|
466 |
|
|
3,463 |
|
|
2,083 |
|
Net amortization of internally developed software costs |
|
1,204 |
|
|
1,252 |
|
|
2,600 |
|
|
2,337 |
|
Gain on sale of business/assets |
|
— |
|
|
(388 |
) |
|
— |
|
|
(36,759 |
) |
Non-GAAP provision for income taxes(1) |
$ |
10,956 |
|
$ |
8,751 |
|
$ |
19,527 |
|
$ |
16,470 |
|
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
||||||||||||
Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income, Non-GAAP Diluted EPS, and EBITDA |
||||||||||||
(in thousands, except per share data, unaudited) |
||||||||||||
|
|
|
|
|
||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||
|
June 30, |
June 30, |
||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||
|
|
|
|
|
||||||||
Net income, as reported |
$ |
17,306 |
|
$ |
10,889 |
|
$ |
21,802 |
|
$ |
143,544 |
|
Adjustments to reconcile net income to non-GAAP net income: |
|
|
|
|
||||||||
Stock-based compensation |
20,147 |
|
15,231 |
|
37,335 |
|
27,333 |
|
||||
Amortization of acquisition-related intangibles and fair value adjustments |
7,875 |
|
1,260 |
|
15,524 |
|
2,643 |
|
||||
Acquisition transaction and integration costs, restructuring charges and other |
2,422 |
|
4,785 |
|
17,025 |
|
14,981 |
|
||||
Net amortization of internally developed software costs |
5,732 |
|
5,963 |
|
12,380 |
|
11,131 |
|
||||
Gain on sale of business/assets |
— |
|
— |
|
— |
|
(159,753 |
) |
||||
Income tax effects and adjustments(1) |
(6,677 |
) |
(4,368 |
) |
(15,273 |
) |
27,643 |
|
||||
Non-GAAP net income |
$ |
46,805 |
|
$ |
33,760 |
|
$ |
88,793 |
|
$ |
67,522 |
|
Non-GAAP net margin |
13.5% |
11.2% |
13.0% |
11.1% |
||||||||
|
||||||||||||
Diluted EPS, as reported |
$ |
0.13 |
|
$ |
0.08 |
|
$ |
0.16 |
|
$ |
1.09 |
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS |
|
|
|
|
||||||||
Stock-based compensation |
0.15 |
|
0.12 |
|
0.28 |
|
0.21 |
|
||||
Amortization of acquisition-related intangibles and fair value adjustments |
0.06 |
|
0.01 |
|
0.12 |
|
0.02 |
|
||||
Acquisition transaction and integration costs, restructuring charges and other |
0.02 |
|
0.04 |
|
0.13 |
|
0.11 |
|
||||
Net amortization of internally developed software costs |
0.04 |
|
0.05 |
|
0.09 |
|
0.08 |
|
||||
Gain on sale of business/assets |
— |
|
— |
|
— |
|
(1.21 |
) |
||||
Income tax effects and adjustments(1) |
(0.05 |
) |
(0.04 |
) |
(0.11 |
) |
0.21 |
|
||||
Non-GAAP diluted EPS |
$ |
0.35 |
|
$ |
0.26 |
|
$ |
0.67 |
|
$ |
0.51 |
|
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||||
|
|
June 30, |
|
June 30, |
||||||||||||||
|
|
2021 |
|
2020 |
|
|
2021 |
|
2020 |
|
||||||||
Net income, as reported |
|
$ |
17,306 |
|
|
$ |
10,889 |
|
|
|
$ |
21,802 |
|
|
$ |
143,544 |
|
|
Adjustments to reconcile net income to EBITDA: |
|
|
|
|
|
|
|
|
||||||||||
Interest expense (income), net |
|
1,110 |
|
|
(945 |
) |
|
|
1,653 |
|
|
(3,168 |
) |
|
||||
Tax expense |
|
4,279 |
|
|
4,383 |
|
|
|
4,254 |
|
|
44,113 |
|
|
||||
Depreciation and amortization |
|
26,152 |
|
|
19,076 |
|
|
|
50,024 |
|
|
38,341 |
|
|
||||
EBITDA |
|
$ |
48,847 |
|
|
$ |
33,403 |
|
|
|
$ |
77,733 |
|
|
$ |
222,830 |
|
|
Weighted average shares outstanding - Diluted |
|
133,539 |
|
|
131,602 |
|
|
|
133,157 |
|
|
131,499 |
|
|
||||
Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS Guidance |
|||||||
(unaudited) |
|||||||
|
Three Months Ended |
||||||
|
September 30, 2021 |
||||||
|
|
|
|||||
|
Low |
High |
|||||
GAAP Diluted EPS, guidance |
$ |
0.10 |
|
$ |
0.24 |
|
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS: |
|
|
|||||
Stock-based compensation |
0.14 |
|
0.14 |
|
|||
Amortization of acquisition-related intangibles and fair value adjustments |
0.06 |
|
0.06 |
|
|||
Acquisition transaction and integration costs, restructuring charges, and other |
0.01 |
|
0.01 |
|
|||
Net amortization of software development costs |
0.04 |
|
0.04 |
|
|||
Income tax effects and adjustments(1) |
(0.04 |
) |
(0.04 |
) |
|||
Non-GAAP Diluted EPS, guidance |
$ |
0.31 |
|
$ |
0.45 |
|
|
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
|||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20210729006058/en/
Contact:
Marissa Vidaurri
Head of Investor Relations
(512) 683-5215